Back

P2y12 inhibitors versus aspirin monotherapy for secondary prevention in patients with established atherosclerotic cardiovascular disease: a systematic review and meta-analysis

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention (1) Secondary Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nikolaos Ktenopoulos

Ippokrateio General Hospital of Athens, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Beta-blocker therapy after myocardial infarction: an umbrella review
Mrs P. Cataldo Miranda (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Improving vaccine uptake after myocardial infarction: results of an opportunistic counselling strategy in cardiac rehabilitation
Doctor V. Marcos Garces (Valencia, ES)
Abstract Slides
Presentation thumbnail
Residual risk in coronary artery disease: identification of cardio–reno–metabolic and psychosocial phenotypes in a Latinamerican cohort of the INTERASPIRE registry
Doctor J. Perea (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Closing the secondary prevention gap in acute coronary syndrome through system-level metabolic risk standardisation
Doctor A. Roy (Ilford, GB)
Abstract Slides
Presentation thumbnail
Achievement of secondary prevention targets after STEMI: results from the IMPACS Study
Doctor R. Molnar (Bratislava, SK)
Abstract Slides

Access the full session

Session thumbnail
Secondary prevention (1)

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparative efficacy and safety of de-escalation, abbreviation, and standard potent P2Y12 inhibitor based DAPT strategies after acute coronary syndrome: a network meta analysis
21 March 2026
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021
thumbnail
Congress Presentation
Statins for venous thromboembolism prevention: old dog, new tricks
1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources